PIK-293

CAS No. 900185-01-5

PIK-293( PIK-293 | PIK 293 | PIK293 )

Catalog No. M17650 CAS No. 900185-01-5

PIK-293 is a PI3K inhibitor, for PI3Kδ( IC50=0.24 μM), and less potent for PI3Kα/β/ γ.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 102 In Stock
2MG 56 In Stock
5MG 92 In Stock
10MG 147 In Stock
25MG 275 In Stock
50MG 407 In Stock
100MG 591 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PIK-293
  • Note
    Research use only, not for human use.
  • Brief Description
    PIK-293 is a PI3K inhibitor, for PI3Kδ( IC50=0.24 μM), and less potent for PI3Kα/β/ γ.
  • Description
    PIK-293 is a PI3K inhibitor, for PI3Kδ( IC50=0.24 μM), and less potent for PI3Kα/β/ γ.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PIK-293 | PIK 293 | PIK293
  • Pathway
    MAPK/ERK Signaling
  • Target
    JNK
  • Recptor
    p110α| p110β| p110γ| p110δ
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    900185-01-5
  • Formula Weight
    397.43
  • Molecular Formula
    C22H19N7O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (125.81 mM)
  • SMILES
    Cc1c2c(ccc1)nc(n(c2=O)c1ccccc1C)Cn1c2c(cn1)c(ncn2)N
  • Chemical Name
    2-((4-amino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-5-methyl-3-o-tolylquinazolin-4(3H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Knight ZA et al. Cell, 2006, 125(4), 733-747.
molnova catalog
related products
  • 6-CFDA N-succinimidy...

    The succinimidyl ester group is capable of spontaneously and irreversibly binding to free amines. Utilized in flow cytometry experiments for tracking cell division in both mammalian cells and bacteria.

  • AS601245.2TFA (34598...

    AS601245.2TFA (345987-15-7 free base) (AS601245.2TFA) is a cell-permeable Inhibitor of JNK (IC50s of 150, 220, and 70 nM for hJNK1, hJNK2, and hJNK3, respectively).

  • JNK-IN-13

    JNK-IN-13 is a selective and potent JNK inhibitor that inhibits JNK3 and JNK2 and can be used in the study of diabetes, inflammation, and neurological disorders.